Top Markets
Coin of the day
European Biotech Acquisition Corp. European Biotech Acquisition Corp.

European Biotech Acquisition Corp.

EBAC
Rank in Stocks #26984
European Biotech Acquisition Corp. (EBAC) is presently not engaged in... European Biotech Acquisition Corp. (EBAC) is presently not engaged in substantial business operations. Instead, its core purpose is to facilitate a business combination, potentially through a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more other companies or organizations. The firm was established in 2021 and its headquarters are located in Amsterdam, the Netherlands.
Share Price
$11.19
Last synced: 2023-03-02
Market Cap
$35.92M
Change (1 day)
-4.44%
Change (1 year)
0.00%
Country
NL
Trade European Biotech Acquisition Corp. (EBAC)
Operating Margin for European Biotech Acquisition Corp. (EBAC)
Operating Margin as of 2026 TTM: 0.00%
According to European Biotech Acquisition Corp. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for European Biotech Acquisition Corp. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
US
0.00% -
US
0.00% -
CN
0.00% -
US
0.00% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.